In This Article:
Expands market-leading position with new best-in-class bunion technologies
PONTE VEDRA, Fla., March 25, 2025 (GLOBE NEWSWIRE) -- Treace Medical Concepts, Inc. ("Treace" or the "Company") (NasdaqGS: TMCI), a medical technology company driving a fundamental shift in the surgical treatment of bunions and related midfoot deformities through its flagship Lapiplasty® and Adductoplasty® Procedures, today announced new technology innovations featured at the 2025 American College of Foot and Ankle Surgeons (“ACFAS”) Annual Scientific Conference in Phoenix, Arizona from March 27-30, 2025.
“We are excited to have another strong presence at ACFAS, highlighting our commitment to surgical podiatry and advancing our company’s focused mission to improve surgical outcomes for bunion patients.” said John T. Treace, CEO, Founder and Board Member of Treace. “We will showcase several new innovations in our expanding and comprehensive bunion portfolio and also look forward to sharing compelling clinical evidence on our flagship Lapiplasty® and Adductoplasty® procedures during podium presentations.”
Treace will feature next-generation technologies at its ACFAS exhibit booth and host surgeon training events on these innovations, including:
-
Latest advancements in our flagship Lapiplasty® and Adductoplasty® platforms; Micro-Lapiplasty™ and Mini-Adductoplasty™ further enabled by our new SpeedPlate™ MicroQuad™ implant, delivering robust, stable fixation for these small incision approaches.
-
Our two new 3D minimally invasive (MIS), instrumented and reproducible osteotomy systems: Nanoplasty™ is designed to expand and accelerate surgeon access to MIS osteotomies and is performed through a small, hidden incision on the side of the foot; and Percuplasty™ is designed to increase reproducibility and speed of percutaneous MIS osteotomy approaches, setting a new standard for surgeons who prefer this approach. Both systems are complemented by our new SpeedAkin™ implant used in Akin osteotomy procedures, which are typically performed in conjunction with MIS osteotomies.
-
SpeedMTP™ provides surgeons with a unique and efficient fusion option to address bunion patients with arthritic great toe (MTP) joints. SpeedMTP™ combines our market leading SpeedPlate™ compression fixation technology with our Fastpitch™ locking screws to deliver an ultra-low profile and highly stable implant designed to support early weight bearing for these patients.
-
IntelliGuide™ PSI cut guides for Lapiplasty® and Adductoplasty® are a first and only in the market, uniquely offering surgeons a pre-op plan, patient specific 3D-printed cut guide and Bone Clone™ anatomic foot model, all produced from the patient’s CT-scan. Our IntelliGuide™ PSI platform is leading a new era of personalized solutions for bunion and midfoot deformity corrections.